Published August 2019

The purpose of this guideline is to systematically assess all randomized controlled trials (RCTs) that evaluated acute migraine treatments in children and adolescents. The guideline seeks to answer the following clinical question: In children and adolescents with migraine, do acute self-administered

Published August 2019

This guideline systematically evaluates new evidence to answer the following clinical question: In children and adolescents with migraines, do preventive pharmacologic treatments, with or without cognitive behavioral therapy (CBT), compared with placebo, reduce headache frequency? Reaffirmed on Oct

Published August 2002

For this parameter, the authors reviewed available evidence on the evaluation of the child with recurrent headaches and made recommendations based on this evidence. Reaffirmed on July 16, 2022.

Published July 1995

The neurologist has long been a resource for patients with headache by excluding serious underlying causes, confirming a correct diagnosis, and planning an effective management strategy. If the EEG is used for patients with headache in some geographic areas or clinical settings and not in others, pa

Published April 2012

The objective of this guideline is to provide updated evidence-based recommendations for the preventive treatment of migraine headache. A new guideline is in development. An updated guideline on nonsteroidal anti-inflammatory drugs and complementary alternative treatments has been approved for publi

Published April 2016

In 2008, the American Academy of Neurology (AAN) published guidelines on the uses of botulinum neurotoxin (BoNT). New research on 4 indications—blepharospasm, cervical dystonia (CD), spasticity, and headache—prompted this update. Reaffirmed on April 30, 2022. Endorsed by the American Association o